Related Experiment Video
Updated: Aug 1, 2026

Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization
Published on: August 4, 2023
Acinetobacter baumannii infection in intensive care unit: analysis of distribution and drug resistance
Siyang Zhao1, Bing Zhang2, Conghai Liu2
1Department of Clinical Research Center, Dazhou Central Hospital, Dazhou, Sichuan province, China.
Background:
The isolation rate and drug resistance rate of Acinetobacter baumannii (A.baumannii) have increased over the years, which has become one of the main causes of infection and death in intensive care unit (ICU) patients. Analysis of the distribution characteristics, drug resistance and influencing factors of A.baumannii in ICU could provide basis and reference for the infection prevention and clinical treatment.
Methods And Results:
In this study, patients diagnosed with A.baumannii infection in ICU from January 2020 to December 2021 were selected. Samples of patients were collected for bacterial culture, drug sensitivity test analysis and drug resistant gene detection of A.baumannii. A total of 197 strains of A.baumannii were cultured in 2021, which was 18 strains more than in 2020. The specimens were mainly from lower respiratory tract secretions, and the isolated strains were multi-drug resistant. The resistance of isolates to tobramycin, gentamicin, and trimethoprim-sulfamethoxazole in 2021 showed a significant increase compared to 2020, while there were no significant differences observed in other resistance changes. The prevalence of multi-drug resistant A.baumannii in ICU remains high. Among them, all imipenem-resistant A.baumannii strains carried OXA-23 gene.
Conclusion:
Clinical treatment should use antibiotics reasonably based on the characteristics of bacterial resistance, and strengthen the prevention and control of hospital infection, pay more attention to the disinfection and isolation to reduce the risk of cross infection.
Insights
Acinetobacter baumannii infections in intensive care units (ICUs) show increasing isolation and drug resistance, particularly multi-drug resistance. All imipenem-resistant strains carried the OXA-23 gene, highlighting the need for enhanced infection control.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Intensive Care Medicine
Background:
- Acinetobacter baumannii (A. baumannii) infections are a growing concern in intensive care units (ICUs), leading to increased morbidity and mortality.
- Rising isolation and drug resistance rates necessitate analysis of A. baumannii characteristics in ICUs.
Purpose of the Study:
- To analyze the distribution, drug resistance, and influencing factors of A. baumannii in ICU patients.
- To provide data for effective infection prevention and clinical treatment strategies.
Main Methods:
- Retrospective analysis of A. baumannii infected patients in the ICU from January 2020 to December 2021.
- Bacterial culture, drug sensitivity testing, and drug-resistant gene detection (OXA-23) were performed on isolated strains.
Main Results:
- A total of 197 A. baumannii strains were isolated in 2021, an increase from 2020. Specimens were primarily from lower respiratory tract secretions.
- Multi-drug resistance in A. baumannii isolates remains high, with significant increases in resistance to tobramycin, gentamicin, and trimethoprim-sulfamethoxazole in 2021 compared to 2020.
- All imipenem-resistant A. baumannii strains harbored the OXA-23 gene.
Conclusions:
- Clinical antibiotic use should be guided by bacterial resistance patterns.
- Strengthening hospital infection prevention and control measures, including disinfection and isolation, is crucial to reduce cross-infection risks.
More Related Videos
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
09:06Author Spotlight: Photodynamic Therapy as a Novel Approach to Induce Petite Colonies in Drug-Resistant Candida for Antifungal Research
Published on: March 29, 2024
Related Concept Videos
Estimation of k and VD of Aminoglycosides
Acute Pyelonephritis II: Diagnostic Studies and Management
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance